0001225208-18-003075.txt : 20180215 0001225208-18-003075.hdr.sgml : 20180215 20180215181708 ACCESSION NUMBER: 0001225208-18-003075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180213 FILED AS OF DATE: 20180215 DATE AS OF CHANGE: 20180215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WILLIAMS RONALD A CENTRAL INDEX KEY: 0001185243 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 18619061 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0101 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 4 1 doc4.xml X0306 4 2018-02-13 0000200406 JOHNSON & JOHNSON JNJ 0001185243 WILLIAMS RONALD A ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 1 Deferred Share Units 2018-02-13 4 A 0 1428.0000 0.0000 A Common Stock 1428.0000 17477.2470 D Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Linda E. King, as attorney-in-fact for Ronald A. Williams 2018-02-15